triple-hormone-receptor agonist retatrutide for obesity - a phase 2 trial Today, we shared new data from two 3 trials of retatrutide, our investigational triple agonist. Learn more at our link in bio retatrutide triple agonist glp-1 gip
Pay in 4 interest-free payments of $5.97 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5






















